Dayah Capital LLC Purchases New Stake in Ingevity Corporation $NGVT

Dayah Capital LLC purchased a new stake in shares of Ingevity Corporation (NYSE:NGVT) during the second quarter, HoldingsChannel reports. The institutional investor purchased 48,073 shares of the company’s stock, valued at approximately $3,590,000. Ingevity makes up approximately 1.2% of Dayah Capital LLC’s portfolio, making the stock its 13th biggest holding.

Several other institutional investors also recently bought and sold shares of the business. Global Retirement Partners LLC purchased a new position in shares of Ingevity in the 4th quarter valued at $27,000. Meeder Asset Management Inc. purchased a new stake in Ingevity during the 4th quarter worth $33,000. Geneos Wealth Management Inc. boosted its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the period. Frazier Financial Advisors LLC purchased a new stake in Ingevity during the 2nd quarter worth $37,000. Finally, Headlands Technologies LLC acquired a new stake in Ingevity in the 2nd quarter valued at $46,000. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Ingevity Trading Up 0.4%

NGVT opened at $69.08 on Wednesday. The firm’s 50 day moving average is $73.72 and its 200-day moving average is $71.84. Ingevity Corporation has a 52-week low of $45.85 and a 52-week high of $79.29. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The firm has a market capitalization of $2.38 billion, a P/E ratio of 46.99 and a beta of 1.16.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.41. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Analysts expect that Ingevity Corporation will post 5.4 EPS for the current fiscal year.

Insider Buying and Selling at Ingevity

In other Ingevity news, SVP Ryan C. Fisher sold 2,709 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the transaction, the senior vice president directly owned 15,722 shares of the company’s stock, valued at $1,159,025.84. This represents a 14.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 18,297 shares of company stock valued at $1,381,452 in the last ninety days. Insiders own 0.88% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on NGVT. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.